Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Enterprise Value (2020 - 2025)

Journey Medical's Enterprise Value history spans 6 years, with the latest figure at -$24.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value fell 18.64% year-over-year to -$24.1 million, compared with a TTM value of -$24.1 million through Dec 2025, down 18.64%, and an annual FY2025 reading of -$24.1 million, down 18.64% over the prior year.
  • Enterprise Value for Q4 2025 was -$24.1 million at Journey Medical, up from -$24.9 million in the prior quarter.
  • The five-year high for Enterprise Value was -$17.0 million in Q2 2023, with the low at -$49.1 million in Q4 2021.
  • Average Enterprise Value over 5 years is -$26.9 million, with a median of -$24.1 million recorded in 2024.
  • Year-over-year, Enterprise Value tumbled 495.21% in 2021 and then surged 57.99% in 2023.
  • Tracing DERM's Enterprise Value over 5 years: stood at -$49.1 million in 2021, then soared by 34.8% to -$32.0 million in 2022, then grew by 14.37% to -$27.4 million in 2023, then rose by 25.89% to -$20.3 million in 2024, then decreased by 18.64% to -$24.1 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Enterprise Value are -$24.1 million (Q4 2025), -$24.9 million (Q3 2025), and -$20.3 million (Q2 2025).